Cargando…

Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio

There is a current demand for “safety signal” screening, not only for single drugs but also for drug-drug interactions. The detection of drug-drug interaction signals using the proportional reporting ratio (PRR) has been reported, such as through using the combination risk ratio (CRR). However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Noguchi, Yoshihiro, Aoyama, Keisuke, Kubo, Satoaki, Tachi, Tomoya, Teramachi, Hitomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822185/
https://www.ncbi.nlm.nih.gov/pubmed/33374503
http://dx.doi.org/10.3390/ph14010004
_version_ 1783639574908502016
author Noguchi, Yoshihiro
Aoyama, Keisuke
Kubo, Satoaki
Tachi, Tomoya
Teramachi, Hitomi
author_facet Noguchi, Yoshihiro
Aoyama, Keisuke
Kubo, Satoaki
Tachi, Tomoya
Teramachi, Hitomi
author_sort Noguchi, Yoshihiro
collection PubMed
description There is a current demand for “safety signal” screening, not only for single drugs but also for drug-drug interactions. The detection of drug-drug interaction signals using the proportional reporting ratio (PRR) has been reported, such as through using the combination risk ratio (CRR). However, the CRR does not consider the overlap between the lower limit of the 95% confidence interval of the PRR of concomitant-use drugs and the upper limit of the 95% confidence interval of the PRR of single drugs. In this study, we proposed the concomitant signal score (CSS), with the improved detection criteria, to overcome the issues associated with the CRR. “Hypothetical” true data were generated through a combination of signals detected using three detection algorithms. The signal detection accuracy of the analytical model under investigation was verified using machine learning indicators. The CSS presented improved signal detection when the number of reports was ≥3, with respect to the following metrics: accuracy (CRR: 0.752 → CSS: 0.817), Youden’s index (CRR: 0.555 → CSS: 0.661), and F-measure (CRR: 0.780 → CSS: 0.820). The proposed model significantly improved the accuracy of signal detection for drug-drug interactions using the PRR.
format Online
Article
Text
id pubmed-7822185
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78221852021-01-23 Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio Noguchi, Yoshihiro Aoyama, Keisuke Kubo, Satoaki Tachi, Tomoya Teramachi, Hitomi Pharmaceuticals (Basel) Article There is a current demand for “safety signal” screening, not only for single drugs but also for drug-drug interactions. The detection of drug-drug interaction signals using the proportional reporting ratio (PRR) has been reported, such as through using the combination risk ratio (CRR). However, the CRR does not consider the overlap between the lower limit of the 95% confidence interval of the PRR of concomitant-use drugs and the upper limit of the 95% confidence interval of the PRR of single drugs. In this study, we proposed the concomitant signal score (CSS), with the improved detection criteria, to overcome the issues associated with the CRR. “Hypothetical” true data were generated through a combination of signals detected using three detection algorithms. The signal detection accuracy of the analytical model under investigation was verified using machine learning indicators. The CSS presented improved signal detection when the number of reports was ≥3, with respect to the following metrics: accuracy (CRR: 0.752 → CSS: 0.817), Youden’s index (CRR: 0.555 → CSS: 0.661), and F-measure (CRR: 0.780 → CSS: 0.820). The proposed model significantly improved the accuracy of signal detection for drug-drug interactions using the PRR. MDPI 2020-12-23 /pmc/articles/PMC7822185/ /pubmed/33374503 http://dx.doi.org/10.3390/ph14010004 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Noguchi, Yoshihiro
Aoyama, Keisuke
Kubo, Satoaki
Tachi, Tomoya
Teramachi, Hitomi
Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title_full Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title_fullStr Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title_full_unstemmed Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title_short Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
title_sort improved detection criteria for detecting drug-drug interaction signals using the proportional reporting ratio
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822185/
https://www.ncbi.nlm.nih.gov/pubmed/33374503
http://dx.doi.org/10.3390/ph14010004
work_keys_str_mv AT noguchiyoshihiro improveddetectioncriteriafordetectingdrugdruginteractionsignalsusingtheproportionalreportingratio
AT aoyamakeisuke improveddetectioncriteriafordetectingdrugdruginteractionsignalsusingtheproportionalreportingratio
AT kubosatoaki improveddetectioncriteriafordetectingdrugdruginteractionsignalsusingtheproportionalreportingratio
AT tachitomoya improveddetectioncriteriafordetectingdrugdruginteractionsignalsusingtheproportionalreportingratio
AT teramachihitomi improveddetectioncriteriafordetectingdrugdruginteractionsignalsusingtheproportionalreportingratio